Reuters Report: How Secrecy in Courts Stymies Safety Regulators January 17, 2020 By Mike Spector, Jaimi Dowdell and Benjamin Lesser LEBANON, Ohio — Something wasn’t right with the Rhino. Reports started trickling in to the Consumer Product Safety Commission (CPSC)...
Facing Thousands of Opioid Lawsuits, Purdue Pharma Files for Bankruptcy Protection September 16, 2019 By Mike Spector OxyContin maker Purdue Pharma LP filed for bankruptcy protection Sunday night, succumbing to pressure from more than 2,600 lawsuits alleging...
Purdue Pharma Floats $10-$12 Billion Opioid Settlement: Reuters August 28, 2019 By Mike Spector and Jessica DiNapoli OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid...
How Insys Bankruptcy Case Could Alter Fate of Thousands of Opioid Lawsuits June 28, 2019 By Mike Spector and Nate Raymond The fate of thousands of lawsuits seeking to hold drugmakers responsible for fueling the U.S. opioid epidemic hinges in part...
With Opioid Litigation Mounting, Purdue Pharma Exploring Bankruptcy: Reuters March 4, 2019 By Mike Spector and Jessica DiNapoli OxyContin maker Purdue Pharma LP is exploring filing for bankruptcy to address potentially significant liabilities from thousands of lawsuits alleging...
PG&E Restructuring Highlights California’s Inverse Condemnation Rule January 15, 2019 By Jessica DiNapoli, Mike Spector and Scott DiSavino PG&E Corp.’s chances of emerging from bankruptcy proceedings hinge in part on an arcane California legal rule that threatens to...
J&J Launches Defense Against Reuters Report on Baby Powder Asbestos December 18, 2018 By Mike Spector Johnson & Johnson on Monday scrambled to contain fallout from a Reuters report that the healthcare conglomerate knew for decades...